PACS Group, Inc.
PACSNYSE
$46.13
↑ +1.1%Jul 17 close · end-of-day
Price
1Y↑ +273.5%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$7.5B
Enterprise Value
$7.5B
P/E
29.8
P/S
1.4
P/B
7.2
EV/EBITDA
—
PEG
21.2
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$5.4B
Net Income (TTM)
$243.8M
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
7.0%
Net Margin
4.5%
ROE
23.5%
ROIC
25.2%
Debt / Equity
0.2
Net Cash
-$218,000.00
Return 1Y
+274.7%
Company profile
We are a leading post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities. PACS Group, Inc. and its subsidiaries that are not licensed healthcare providers do not provide healthcare services to patients, residents or any other person, and do not direct or control the provision of services provided. All healthcare services are provided solely by applicable subsidiaries that are licensed healthcare providers, under the direction and control of licensed healthcare professionals in accordance with applicable law. Our principal executive offices are located at 262 N. University Ave, Farmington, Utah.
- CEO
- Jason Murray
- Sector
- Services
- Industry
- Healthcare
- Headquarters
- Utah
- Website
- pacs.com
Management & directors
- Jergensen JoshuaPresident & COO
- Lewis Michelle ReneeChief Accounting Officer
- Hancock MarkCo Fndr; Int CFO; Exec V Chair
- Mitchell John ToddChief Legal Officer & Sec.
- Hendrickson Carey PChief Financial Officer
- Bingham Trent DeanChief Human Resources Officer
- Murray Jason HulseCo-Founder, CEO & Chairman
- Priegnitz KellyChief Compliance Officer
Roles derived from SEC Form 4 filings.
Earnings
PACS Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$1.4B↑ +11.2%
Diluted EPS$0.50↑ +194.1%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $2.4B | $3.1B | $4.1B | $5.3B |
| Gross profit | — | — | — | — |
| Operating income | $229.4M | $207.8M | $123.1M | $309.6M |
| Net income | $150.5M | $112.9M | $55.8M | $191.5M |
| Diluted EPS | $1.17 | $0.88 | $0.38 | $1.22 |
| Operating cash flow | $92.6M | $63.7M | $367.3M | $404.2M |
| Free cash flow | — | — | — | — |
| Gross margin | — | — | — | — |
| Operating margin | 9.5% | 6.7% | 3.0% | 5.9% |
| Net margin | 6.2% | 3.6% | 1.4% | 3.6% |
| Line item | Q3 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $935.7M | $1.0B | $1.2B | $1.3B | $1.3B | $1.3B | $1.4B | $1.4B |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$37.2M | $23.0M | $72.0M | $48.1M | $80.5M | $86.3M | $94.7M | $120.0M |
| Net income | -$31.9M | $15.6M | $37.2M | $28.5M | $51.0M | $52.4M | $59.7M | $80.7M |
| Diluted EPS | -$0.21 | $0.10 | $0.22 | $0.17 | $0.31 | $0.32 | $0.42 | $0.50 |
| Operating cash flow | $34.8M | $209.2M | $64.6M | $150.2M | $52.6M | $204.8M | -$3.4M | $236.3M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | -4.0% | 2.2% | 6.0% | 3.8% | 6.1% | 6.4% | 7.0% | 8.5% |
| Net margin | -3.4% | 1.5% | 3.1% | 2.2% | 3.9% | 3.9% | 4.4% | 5.7% |
Company news
Jul 14, 2026
Jun 16, 2026
May 18, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-15 | Jergensen Joshua· President & COO | Sale | 32,327 | $45.13 | $1.5M | filing |
| 2026-07-15 | Jergensen Joshua· President & COO | Sale | 7,440 | $44.50 | $331,067.35 | filing |
| 2026-07-15 | Hancock Mark | Sale | 3,332 | $45.05 | $150,114.93 | filing |
| 2026-07-15 | Jergensen Joshua· President & COO | Sale | 233 | $45.76 | $10,661.73 | filing |
| 2026-07-14 | Hancock Mark | Sale | 10,296 | $45.04 | $463,680.36 | filing |
| 2026-07-09 | Hancock Mark | Sale | 4,966 | $45.06 | $223,781.37 | filing |
| 2026-07-08 | Hancock Mark | Sale | 20,338 | $45.07 | $916,611.29 | filing |
| 2026-07-06 | Hancock Mark | Sale | 142,163 | $45.33 | $6.4M | filing |
| 2026-07-06 | Lewis Michelle Renee· Chief Accounting Officer | Sale | 4,137 | $45.04 | $186,332.96 | filing |
| 2026-07-02 | Hancock Mark | Sale | 12,825 | $45.01 | $577,290.44 | filing |
| 2026-07-02 | Lewis Michelle Renee· Chief Accounting Officer | Sale | 6,663 | $45.03 | $300,032.22 | filing |
| 2026-07-01 | Hancock Mark | Sale | 6,080 | $45.02 | $273,716.13 | filing |
| 2026-07-01 | Lewis Michelle Renee· Chief Accounting Officer | Sale | 4,200 | $45.01 | $189,059.22 | filing |
| 2026-07-01 | Conway Patrick Hugh | Award | 4,287 | $0.00 | $0.00 | filing |
| 2026-07-01 | Hancock Mark | Award | 4,287 | $0.00 | $0.00 | filing |
| 2026-07-01 | Millard Jacqueline | Award | 4,287 | $0.00 | $0.00 | filing |
| 2026-07-01 | LEAVITT TAYLOR S. | Award | 4,287 | $0.00 | $0.00 | filing |
| 2026-07-01 | Dilsaver Evelyn S | Award | 4,287 | $0.00 | $0.00 | filing |
| 2026-06-26 | Hancock Mark· Co Fndr; Exec V Chair | Sale | 61,731 | $40.50 | $2.5M | filing |
| 2026-06-26 | Hancock Mark· Co Fndr; Exec V Chair | Sale | 200 | $41.01 | $8,202.00 | filing |
| 2026-06-25 | Hancock Mark· Co Fndr; Exec V Chair | Sale | 138,069 | $40.33 | $5.6M | filing |
| 2026-06-25 | Lewis Michelle Renee· Chief Accounting Officer | Sale | 15,000 | $40.01 | $600,178.50 | filing |
| 2026-06-17 | Hancock Mark· Co Fndr; Exec V Chair | Sale | 60,364 | $35.28 | $2.1M | filing |
| 2026-06-17 | Hancock Mark· Co Fndr; Exec V Chair | Sale | 3,316 | $35.75 | $118,544.02 | filing |
| 2026-06-16 | Hancock Mark· Co Fndr; Exec V Chair | Sale | 83,066 | $35.90 | $3.0M | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.